Pratik S. Multani
Chief Medical Officer, Fate Therapeutics.
Companies
- Erasca, Inc.Board member Jul 15, 2021 to now1
- Oric Pharmaceuticals, Inc.Chief Business Officer Apr 23, 2020 to now2
- Chimerix (United States)Board member Feb 25, 2020 to now3
- Fate TherapeuticsChief Medical Officer Sep 30, 2013 to Jan 7, 20154
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Erasca, Inc. ERAS172,866 shares5$2.6M at $15.00May 23, 2025
- Oric Pharmaceuticals, Inc. ORIC68,149 shares6$870.3K at $12.77Dec 16, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 16, 2025Sold 10,720 shares at $9.06 of Oric Pharmaceuticals, Inc.6
- Dec 15, 2025Exercised options 29,333 shares of Oric Pharmaceuticals, Inc.6
- May 23, 2025Gift 6,200 shares of Erasca, Inc.5
- May 23, 2025Gift 6,200 shares of Erasca, Inc.5
- Dec 16, 2024Sold 8,850 shares at $8.28 of Oric Pharmaceuticals, Inc.7
- Dec 15, 2024Exercised options 24,042 shares of Oric Pharmaceuticals, Inc.7
- Dec 15, 2023Sold 5,282 shares at $8.59 of Oric Pharmaceuticals, Inc.8
- Dec 15, 2023Exercised options 14,042 shares of Oric Pharmaceuticals, Inc.8
- Dec 15, 2022Sold 2,089 shares at $3.25 of Oric Pharmaceuticals, Inc.9
- Dec 15, 2022Exercised options 6,041 shares of Oric Pharmaceuticals, Inc.9
- Dec 15, 2022Sold 2,227 shares at $3.07 of Oric Pharmaceuticals, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARErasca, Inc., Board member
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Dec 17, 2024
- 8SEC EDGARForm 4 filed Dec 19, 2023
- 9SEC EDGARForm 4 filed Dec 16, 2022
- 10SEC EDGARForm 4 filed Feb 17, 2023